WINNIPEG, MANITOBA--(Marketwire - June 04, 2008) - Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company, dedicated to the discovery and development of diagnostic tools and therapeutic products for cancer, is pleased to announce that it has added a Luminex Bio-Plex 200 Protein Array System to its laboratory which will enhance the Company’s capabilities to develop clinical grade immunoassays internally.
